 |
|
 |
Latin America |
|
|
The Pharmaceutical Market: Colombia
Publication Date August 2006
Publisher Espicom
Product Type Strategic Report
Pages 126
ISBN Number not applicable
Product Code ESP508
|
|
|
Summary
Along with many other Latin American countries, the health sector in Colombia has suffered from insufficient financing and a highly uneven distribution of healthcare resources. During the 1990s, the situation changed following the adoption of a new constitution in July 1991, which produced a far-reaching programme of political and social reform.
In the health sector, the country embarked on an ambitious reform of the social security system with the aim of providing universal healthcare coverage. Although the reform process was stalled by the country's economic recession in 1999, Colombia remains committed to the principle of universal healthcare coverage. In 2004, there were 45.3 million people living in Colombia, 71.1% of whom were insured.
The Colombian pharmaceutical market is the fifth largest in the region, behind Mexico, Brazil, Argentina and Venezuela. The healthcare reform programme has been instrumental in boosting consumption of pharmaceutical products, but growth has been largely in volume terms, due to a shift towards generics. Around 70% of the market is supplied by the well-developed domestic industry.
The domestic industry is dominated by multinationals. Major indigenous manufacturers include Bussie, Genfar, Lafrancol, La Sant, Procaps and Tecnoqumicas. However, the country has a sizeable balance of trade deficit in the field of pharmaceuticals, valued at US$295.1 million in 2004, partly due to the fact that the domestic industry is heavily dependent on imports of raw materials.
In February 2006, Colombia and the USA announced an agreement to go ahead with a bilateral Free Trade Agreement (FTA). In terms of intellectual property rights, Colombia was able to avoid the granting of second uses, or diagnostic, surgical & therapeutic proceedings. The five-year data exclusivity period was kept. Lack of linkage, compulsory licensing and parallel imports remain, guaranteeing healthcare access.
After the publication of Circular 3 in 2006, the National Commission of Drug Prices (CNPM - Comisin Nacional de Precios de Medicamentos) continues to postpone the regulatory reform to transform the current drug price system in Colombia. In December 2005, CNPM had approved the adoption of the new drug price system, which would have been enforceable from 1st July 2006.
These pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
|
Content
Background Data
- Geography
- Political Overview
- Economic Overview
- Population
- Projected Population,
- Population by Administrative Divisions, 1993 Census
- Population by Age Group,
- Population by Age Group, 1993-2005 (%)
- Projected Population by Age Group,
- Projected Population by Age Group, 2010-2050 (%)
- Demographic Indicators
- Mortality
- Summary of Leading Causes of Death,
- Summary of Leading Causes of Death, 2001-2003 (%)
- Change in Leading Causes of Death, 2001-2003 (%)
- Causes of Death,
- Morbidity
- Vaccination Coverage, 2000-2004 (%)
- Morbidity Incidence,
- Tuberculosis
- Leprosy
- HIV/AIDS
- HIV/AIDS Cases,
- HIV/AIDS Cases, 1983-2002 (%)
- Main Causes of HIV/AIDS Infection, Cumulative
- HIV/AIDS Cases by Age Group, Cumulative
- ____________________________________________________________________
- Charts
- Map of Colombia
- Leading Causes of Death, 2003 (%)
- Chichester, West Sussex, PO20 2FS, United Kingdom
Healthcare System
- Organisation & Administration
- Entities Within the Ministry of Social Protection,
- Universal Health Insurance
- Subsidised & Contributive UPC,
- Affiliates to the Contributory Scheme by Department,
- Affiliates to the Subsidised Scheme by Department,
- Affiliates to the Subsidised Scheme by Department & Type of Coverage,
- Affiliates to the Subsidised Scheme by Provider,
- Health Expenditure
- Health Expenditure Projections,
- Health Expenditure by Source of Funding,
- Health Expenditure,
- Change in Health Expenditure, 1994-2002 (%)
- Health Expenditure at Constant Prices by Sector, 1994-2002 (Billion Pesos)
- Health Expenditure at Constant Prices as % of Total,
- Change in Health Expenditure at Constant Prices, 1994-2002 (%)
- Combined Healthcare Providers
- Healthcare Providers by Location,
- Healthcare Providers by Location, 2005 (%)
- IPS' Medical Services by Type,
- Hospital Services
- Hospital Beds by Type of Service,
- Public Hospitals
- Public IPS' by Type & Level,
- Public IPS' by Type & Level, 2004 (%)
- Public IPS' by ESE Status,
- Public IPS' Medical Activity,
- Change in Public IPS' Medical Activity, 2003-2004 (%)
- Bed Occupancy in Public IPS', 2002-2004 (%)
- ALOS in Public IPS',
- Bed Turnover in Public IPS', 2002-2004 (%)
- Public Hospital Indicators,
- Public Hospital Indicators as % of Total,
- Public Tertiary & Secondary Hospital Beds,
- Public Tertiary & Secondary Hospital Bed Turnover,
- Public Tertiary & Secondary Hospital Bed Occupancy,
- Public Tertiary & Secondary Hospital ALOS,
- Public Tertiary & Secondary Hospital Discharges,
- Colombia Healthcare System
- Public Tertiary & Secondary Hospital Discharges by Normal Childbirth, 1996-2002 (%)
- Public Tertiary & Secondary Hospital Outpatient Consultations,
- Public Tertiary & Secondary Hospital Emergency Consultations,
- Public Tertiary & Secondary Hospital Surgical Procedures,
- PublicTertiary & Secondary Hospital Childbirths,
- Public Tertiary & Secondary Hospital Childbirths by Caesarean Section, 1996-2002 (%)
- Public Tertiary & Secondary Hospitals & Beds by Department,
- Public Hospitals Contracted by ISS
- ESEs Contracted by ISS,
- Hospitals by ESE,
- Military Hospitals
- Private Hospitals
- Ambulatory Care
- Establishments Offering Ambulatory Care by Sector,
- Public Establishments Offering Ambulatory Care, June
- Medical Consultations by Principal Cause,
- Medical Personnel
- Medical Personnel by Category & Type of Municipality,
- Specialists by Type of Municipality,
- Charts
- Distribution of the Population by Type of Coverage,
- Affiliates to the Contributory & Subsidised Schemes by Deparment,
- Health Expenditure Projections,
- Health Expenditure as Percentage of GDP,
- Public IPS' by Level, 2004 (%)
- Public IPS' by ESE Status, 2004 (%)
- Bed Occupancy in Public IPS', 2002-2004 (%)
- Chichester, West Sussex, PO20 2FS, United Kingdom
- Accessing The Pharmaceutical
- Market
Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
- Pharmaceutical Registration & Drug Approval Process
- Drug Registrations,
- Registration of Officially Accepted Drugs
- Registration of New Drugs
- Import Certification
- Lettering & Labelling
- Drug Quality Control
- Counterfeiting
- Advertising
- Patent Protection & Intellectual Property Rights
- Summary of the US-Colombian FTA's Intellectual Property Agreements,
- Pricing & Reimbursement
- Potential Drug Pricing Classification,
- I Potential Drug Pricing Classification, 2005 (%)
- II Potential Drug Pricing Classification, 2005 (%)
- Drug Price Discounts at Wholesalers' Prices in the Institutional Sector, 2003-2004 (%)
- Distribution Channels
- Direct Pharmaceutical Sales Distribution Channels, 1999-2003 (%)
- Pharmacies
- Domestic Production
- Pharmaceutical Production Indicators, 2004 (Million Pesos)
- Pharmaceutical Production Indicators, 2004 (US$ Million)
- Pharmaceutical Production, 1995-2004 (At Constant Prices, 2004)
- Pharmaceutical Production by Type,
- GMP-Certified Producers, March
- International Pharmaceutical Manufacturing Capabilities,
- Trade Associations
- Afidro
- Asinfar
- Cecif
- Members of CECIF,
- Trade Fairs
- Colombia Accessing The Pharmaceutical Market
- LatinPharma
- Domestic Producers
- America
- Baxter
- Bayer
- Beiersdorf
- Boehringer Ingelheim
- Ecar
- Genfar
- Lafrancol
- La Sant
- Lutecia
- Merck
- Sanofi-Aventis
- Schering Colombiana
- Tecnoqumicas
- Research & Development
- Directory
- Government Organisations
- Trade Associations
- ____________________________________________________________________
- Charts
- Pharmaceutical Presentations & Active Ingredients,
- Direct Pharmaceutical Sales Distribution Channels, 1999-2003 (%)
- Pharmaceutical Production, 1995-2004 (At Constant Prices, 2004)
- Pharmaceutical Production by Type, 2004 (%)
- Human Pharmaceutical Production,
|
|
|
